Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutationsEmilee Senkevitch(National Cancer Institute), Scott K. Durum(National Institutes of Health)OncotargetApril 27, 201810.18632/oncotarget.25194Cited by 44SaveCiteExport RISWatch citationsRelated PapersVisualization and Identification of IL-7 Producing Cells in Reporter Mice|PLoS ONE|2009|112